Cognitive-Somatosensory-Motor Training for Stroke
(iCOSMO Trial)
Trial Summary
The trial protocol does not specify whether you need to stop taking your current medications.
The available research shows that Cognitive-Somatosensory-Motor Training can improve motor function in stroke patients. For example, one study found that somatosensory stimulation, which is part of this training, led to better hand motor function in patients with chronic strokes. This improvement was greater than in sessions without this stimulation, and the benefits lasted for at least 30 days. This suggests that the treatment can be a helpful tool in stroke rehabilitation, especially for those with certain types of brain injuries.
12345The provided research does not directly address safety data for Cognitive-Somatosensory-Motor Training or its variants like iCOSMO. The studies focus on the effectiveness of somatosensory retraining and stimulation in improving motor function after stroke, but they do not specifically mention safety outcomes or adverse effects related to these interventions.
13467Yes, Cognitive-Somatosensory-Motor Training for Stroke is promising because it combines physical and sensory training to improve motor and sensory functions in stroke patients. Studies show that somatosensory stimulation can enhance motor function and help maintain training benefits, making it a valuable tool for stroke rehabilitation.
23468Eligibility Criteria
The iCOSMO trial is for individuals who have had a stroke and are looking to improve the function of their arm and hand. Specific eligibility criteria details were not provided.Inclusion Criteria
Exclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Baseline
Participants are tested at the start and end of the baseline phase
Treatment
Participants receive the iCOSMO intervention or a home-based exercise programme for 6 weeks
Follow-up
Participants are monitored for safety and effectiveness after treatment